Trial Details

COMPLETED
Basic Information
Clinical ID c2685
Identifier NCT03107793
Trial Title Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn Disease
Interventions DRUG: Ustekinumab
Participant Information
Sponsor Janssen-Cilag Ltd.
City Antwerp
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2017-04-19
Primary Completion Date 2020-04-30
Completion Date 2021-07-20